A cyclized form of glutamic acid
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

DL-Pyroglutamic Acid

Item No. 36375

Technical Information
Formal Name
5-oxo-proline
CAS Number
149-87-1
Synonyms
  • NSC 40887
  • 5-oxo-DL-Proline
  • (±)-Pyroglutamic Acid
Molecular Formula
C5H7NO3
Formula Weight
Purity
≥95%
A solid
DMF: 5 mg/mlDMSO: 10 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
202 nm
SMILES
O=C1CCC(C(O)=O)N1
InChi Code
InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)
InChi Key
ODHCTXKNWHHXJC-UHFFFAOYSA-N
Origin
Synthetic
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    DL-Pyroglutamic acid is a cyclized form of glutamic acid that has been found in E. aureum and is a racemic mixture of the D-glutamate metabolite D-pyroglutamic acid (Item No. 31170) and the L-glutamate and L-glutamine metabolite L-pyroglutamic acid (Item No. 36531).1 A DL-pyroglutamic acid-magnesium complex decreases immobility time in the forced swim test and increases the latency to paw withdrawal in the hot plate test in rats.2 DL-Pyroglutamic acid has been used as a building block in the synthesis of GABA peptides with antinociceptive activity in rats.3 Plasma levels of D- and L-pyroglutamic acid are increased in patients with end-stage renal disease.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Meshram, A., Bhagyawant, S.S., and Srivastava, N. Characterization of pyrrolidine alkaloids of Epipremnum aureum for their antitermite activity against subterranean termites with SEM studies. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 89(1), 53-62 (2019).

    2. Martini, N., Parente, J.E., Toledo, M.E., et alAntidepressant and antinociceptive activities in animal models and in vitro assessment of the anti-thyroid activity of bis(DL-pyroglutamate)magnesium complex. Pharmacol. Rep. 71(6), 1273-1280 (2019).

    3. Adamyan, N.H., Topchyan, H.V., Poghosyan, V.H., et alSynthesis and antinociceptive activity of GABA and pyroglutamic acid short peptides. Pharm. Chem. J. 56, 339–344 (2022).

    4. Palekar, A.G., Tate, S.S., Sullivan, J.F., et alAccumulation of 50oxo-L-proline and 5-oxo-D-proline in the blood plasma in end stage renal disease. Biochem. Med. 14(3), 339-345 (1975).